| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.025 | 0.7 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.026 | 0.7 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | 0.038 | 0.5 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.04 | 0.5 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.061 | 0.3 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.07 | 0.2 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.1 | 0.05 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | 0.14 | 0.01 |